Latest Growth Initiatives News

Microba Life Sciences delivered a mixed FY26, with overall revenue slipping 5.8% to $14.76 million and a statutory loss widening 38.7% to $20.7 million. The company’s strategic pivot to core microbiome testing paid off with a 92% surge in core testing revenue and record test volumes in Australia and the UK. Despite the headline loss, underlying loss improved 11% thanks to cost cuts and AI-driven efficiencies. Microba is gearing up for the October launch of its GI Navigator diagnostic and targeting cash flow break-even on a run-rate basis in calendar 2027.

The Calmer Co. International Limited posted a record $8.1 million revenue for FY26, driven by retail and wholesale growth, yet recorded a $3.8 million net loss amid ongoing funding challenges and strategic investments.

Xref Limited’s FY26 results show a 76% jump in underlying EBITDA to A$4.7 million, underpinned by strong adoption of its new platform. The company also refinanced its debt with Commonwealth Bank, easing near-term repayments and boosting liquidity.

The Star Entertainment Group narrowed its net loss to $307 million in FY26, boosted by refinancing, operational improvements, and a joint venture exit, while navigating ongoing regulatory scrutiny and remediation efforts.

West Wits Mining has transitioned from developer to producer with first gold poured at Qala Shallows, backed by a $97 million project finance package and a resource base expanded to 7.24 million ounces.

C29 Metals has locked in binding commitments for a $2.4 million share placement at 1.2 cents per share, pending shareholder approval at the upcoming AGM. The funds aim to accelerate exploration at its Sampsons Tank project and fuel global acquisition ambitions.

Kingsgate Consolidated delivered a record FY2026 net profit of $278 million, driven by strong gold and silver output at Chatree and a $68.6 million impairment reversal at the Nueva Esperanza project, while declaring a 10 cent final dividend.

Nexsen Limited (ASX:NXN) reported a 30% rise in net loss to $6.55 million for FY26, driven by ongoing investment in its Group B Streptococcus rapid diagnostic and Asia-Pacific growth initiatives following its October 2025 IPO.

FlexiRoam Limited (ASX:FRX) reported a statutory net profit after tax of $0.7 million for FY26, reversing a $2.0 million loss in FY25, driven by a pivot to higher-quality recurring revenue and operational discipline.

First Graphene lifted revenue by 15% to $537,594 for FY26 while narrowing its net loss slightly to $5.4 million. Key acquisitions and a landmark China cement distribution MOU set the stage for commercial expansion.

RooLife Group (ASX: RLG) reported a 268% jump in FY2026 revenue to nearly $10 million, driven by rapid growth in its own food and beverage products, including RLG Coffee in China. Despite this, the company recorded a $3.58 million net loss, weighed down by impairment charges and R&D investments in renewable energy.

Boresight Ltd (ASX: BST) recorded a 46% increase in revenue to $6.38 million for FY26, driven by global sales expansion and strategic investments including an $8 million IPO. Despite this growth, the company posted a $6.66 million net loss, largely due to increased operational expenses and significant share-based payments.